Plasma and Urinary Metabolomic Analysis of Gout and Asymptomatic Hyperuricemia and Profiling of Potential Biomarkers: A Pilot Study
Gout results from monosodium urate deposition caused by hyperuricemia, but most individuals with hyperuricemia remain asymptomatic. The pathogenesis of gout remains uncertain. To identify potential biomarkers distinguishing gout from asymptomatic hyperuricemia, we conducted a genetic analysis of ura...
Main Authors: | Yuki Ohashi, Hiroshi Ooyama, Hideki Makinoshima, Tappei Takada, Hirotaka Matsuo, Kimiyoshi Ichida |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/12/2/300 |
Similar Items
-
Progress on the role of ABCG2 and SLC2A9 in the onset of hyperuricemia and gout
by: YANG Lijuan, DONG Qiumei, WU Hao
Published: (2023-09-01) -
The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout—An Update
by: Robert Eckenstaler, et al.
Published: (2021-06-01) -
The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
by: Blanka Stiburkova, et al.
Published: (2019-03-01) -
The Role of the Intestine in the Development of Hyperuricemia
by: Hui Yin, et al.
Published: (2022-02-01) -
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
by: Rebekah Wrigley, et al.
Published: (2020-03-01)